Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02566733Phase 4Completed
A Phase 4 trial of remifentanil in pain, sponsored by Seoul National University Hospital. Started Oct 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02566733.